Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169746343> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3169746343 abstract "Ranibizumab monotherapy showed stronger effects on area of retinal neovascularization (NV) reduction while offering better visual acuity (VA) results than panretinal laser photocoagulation (PRP) monotherapy during the first 12 months of the PRIDE study. The second year of PRIDE was an observational, non-interventional follow-up, performed to evaluate long-term anatomical and functional outcomes in proliferative diabetic retinopathy (PDR) patients under real-life conditions, prior to the approval of ranibizumab for PDR.Seventy-three PDR patients (28 from the ranibizumab group; 20 from the PRP group; 25 from the combination group) were included in the observational follow-up phase and treated at the investigators discretion. Visual acuity (VA) measurements and retinal imaging were performed at Months 12, 18 and 24.Mean (± SD) NV area in the ranibizumab monotherapy and combination follow-up groups increased from 3.16 ± 4.30 mm2 and 1.13 ± 2.78 mm2 at Month 12 to 6.09 ± 10.79 mm2 and 2.14 ± 4.41 mm2 at Month 18 and 10.00 ± 17.63 mm2 and 3.26 ± 7.05 mm2 at Month 24, respectively. In the PRP follow-up group, NV area declined from 5.44 ± 14.55 mm2 at Month 12 to 1.22 ± 1.67 mm2 at Month 18, but increased again to 4.05 ± 11.66 mm2 at Month 24. During the observational phase, only 2 (6;8) patients in the ranibizumab (PRP;combination) follow-up group were treated with anti-VEGF medications, while 17 (6;10) patients received PRP laser therapy.Discontinuation of ranibizumab treatment in PDR patients may result in an increase of NV area and VA loss. Tight monitoring of disease activity and continued treatment beyond the first year is needed to maintain disease control." @default.
- W3169746343 created "2021-06-22" @default.
- W3169746343 creator A5010607087 @default.
- W3169746343 creator A5011101272 @default.
- W3169746343 creator A5017371808 @default.
- W3169746343 creator A5034062166 @default.
- W3169746343 creator A5041500951 @default.
- W3169746343 creator A5063141518 @default.
- W3169746343 creator A5068316441 @default.
- W3169746343 creator A5081348324 @default.
- W3169746343 date "2021-06-14" @default.
- W3169746343 modified "2023-10-16" @default.
- W3169746343 title "Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy – The non‐interventional second year follow‐up to the PRIDE study" @default.
- W3169746343 cites W1915008606 @default.
- W3169746343 cites W1997026470 @default.
- W3169746343 cites W2042978638 @default.
- W3169746343 cites W2138480916 @default.
- W3169746343 cites W2178156144 @default.
- W3169746343 cites W2184099408 @default.
- W3169746343 cites W2324588265 @default.
- W3169746343 cites W2406931263 @default.
- W3169746343 cites W2416146661 @default.
- W3169746343 cites W2883798682 @default.
- W3169746343 cites W2886506590 @default.
- W3169746343 cites W2972391601 @default.
- W3169746343 cites W2991811333 @default.
- W3169746343 cites W3029735689 @default.
- W3169746343 cites W4211229182 @default.
- W3169746343 cites W4232979084 @default.
- W3169746343 cites W4240531687 @default.
- W3169746343 doi "https://doi.org/10.1111/aos.14907" @default.
- W3169746343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34121335" @default.
- W3169746343 hasPublicationYear "2021" @default.
- W3169746343 type Work @default.
- W3169746343 sameAs 3169746343 @default.
- W3169746343 citedByCount "2" @default.
- W3169746343 countsByYear W31697463432021 @default.
- W3169746343 crossrefType "journal-article" @default.
- W3169746343 hasAuthorship W3169746343A5010607087 @default.
- W3169746343 hasAuthorship W3169746343A5011101272 @default.
- W3169746343 hasAuthorship W3169746343A5017371808 @default.
- W3169746343 hasAuthorship W3169746343A5034062166 @default.
- W3169746343 hasAuthorship W3169746343A5041500951 @default.
- W3169746343 hasAuthorship W3169746343A5063141518 @default.
- W3169746343 hasAuthorship W3169746343A5068316441 @default.
- W3169746343 hasAuthorship W3169746343A5081348324 @default.
- W3169746343 hasBestOaLocation W31697463431 @default.
- W3169746343 hasConcept C118487528 @default.
- W3169746343 hasConcept C126322002 @default.
- W3169746343 hasConcept C134018914 @default.
- W3169746343 hasConcept C141071460 @default.
- W3169746343 hasConcept C23131810 @default.
- W3169746343 hasConcept C2776694085 @default.
- W3169746343 hasConcept C2776999253 @default.
- W3169746343 hasConcept C2777802072 @default.
- W3169746343 hasConcept C2778257484 @default.
- W3169746343 hasConcept C2778715236 @default.
- W3169746343 hasConcept C2779829184 @default.
- W3169746343 hasConcept C2780827179 @default.
- W3169746343 hasConcept C2781100027 @default.
- W3169746343 hasConcept C555293320 @default.
- W3169746343 hasConcept C71924100 @default.
- W3169746343 hasConceptScore W3169746343C118487528 @default.
- W3169746343 hasConceptScore W3169746343C126322002 @default.
- W3169746343 hasConceptScore W3169746343C134018914 @default.
- W3169746343 hasConceptScore W3169746343C141071460 @default.
- W3169746343 hasConceptScore W3169746343C23131810 @default.
- W3169746343 hasConceptScore W3169746343C2776694085 @default.
- W3169746343 hasConceptScore W3169746343C2776999253 @default.
- W3169746343 hasConceptScore W3169746343C2777802072 @default.
- W3169746343 hasConceptScore W3169746343C2778257484 @default.
- W3169746343 hasConceptScore W3169746343C2778715236 @default.
- W3169746343 hasConceptScore W3169746343C2779829184 @default.
- W3169746343 hasConceptScore W3169746343C2780827179 @default.
- W3169746343 hasConceptScore W3169746343C2781100027 @default.
- W3169746343 hasConceptScore W3169746343C555293320 @default.
- W3169746343 hasConceptScore W3169746343C71924100 @default.
- W3169746343 hasFunder F4320332736 @default.
- W3169746343 hasIssue "2" @default.
- W3169746343 hasLocation W31697463431 @default.
- W3169746343 hasLocation W31697463432 @default.
- W3169746343 hasOpenAccess W3169746343 @default.
- W3169746343 hasPrimaryLocation W31697463431 @default.
- W3169746343 hasRelatedWork W2062091766 @default.
- W3169746343 hasRelatedWork W2080677442 @default.
- W3169746343 hasRelatedWork W2093126039 @default.
- W3169746343 hasRelatedWork W2178156144 @default.
- W3169746343 hasRelatedWork W2612234138 @default.
- W3169746343 hasRelatedWork W2765502507 @default.
- W3169746343 hasRelatedWork W2790038519 @default.
- W3169746343 hasRelatedWork W3032094931 @default.
- W3169746343 hasRelatedWork W3134304631 @default.
- W3169746343 hasRelatedWork W4362511091 @default.
- W3169746343 hasVolume "100" @default.
- W3169746343 isParatext "false" @default.
- W3169746343 isRetracted "false" @default.
- W3169746343 magId "3169746343" @default.
- W3169746343 workType "article" @default.